Service Tax Additional
select a format
Recent Viewed Reports
Why Ken Reasearch?
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"
Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"
We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"
Avail a 10% Discount and 10% cash back on all Publications; Not Applicable on Ken Research's publications; Available on all License types; Limited Time Period Offer; T&C apply
• Promo code can be used 1 time per user
Acumen Pharmaceuticals, Inc.-Product Pipeline Review-2015
Global Markets Direct's, 'Acumen Pharmaceuticals, Inc.-Product Pipeline Review-2015', provides an overview of the Acumen Pharmaceuticals, Inc.'s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Acumen Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
The report provides brief overview of Acumen Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Acumen Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Acumen Pharmaceuticals, Inc.'s pipeline products
Reasons To Buy
Evaluate Acumen Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Acumen Pharmaceuticals, Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Acumen Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Acumen Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acumen Pharmaceuticals, Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Acumen Pharmaceuticals, Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Acumen Pharmaceuticals, Inc. Snapshot 4
Acumen Pharmaceuticals, Inc. Overview 4
Key Information 4
Key Facts 4
Acumen Pharmaceuticals, Inc.-Research and Development Overview 5
Key Therapeutic Areas 5
Acumen Pharmaceuticals, Inc.-Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products-Monotherapy 8
Acumen Pharmaceuticals, Inc.-Pipeline Products Glance 9
Acumen Pharmaceuticals, Inc.-Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Acumen Pharmaceuticals, Inc.-Drug Profiles 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
ACU-193 Back-up 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Drugs to Inhibit ADDL Receptor for Alzheimer's Disease 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Vaccine to Target ADDL for Alzheimer's Disease 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Acumen Pharmaceuticals, Inc.-Pipeline Analysis 15
Acumen Pharmaceuticals, Inc.-Pipeline Products by Target 15
Acumen Pharmaceuticals, Inc.-Pipeline Products by Molecule Type 16
Acumen Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action 17
Acumen Pharmaceuticals, Inc.-Recent Pipeline Updates 18
Acumen Pharmaceuticals, Inc.-Dormant Projects 19
Acumen Pharmaceuticals, Inc.-Locations And Subsidiaries 20
Head Office 20
Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 21
List of Tables
Acumen Pharmaceuticals, Inc., Key Information 4
Acumen Pharmaceuticals, Inc., Key Facts 4
Acumen Pharmaceuticals, Inc.-Pipeline by Indication, 2015 6
Acumen Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 7
Acumen Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 8
Acumen Pharmaceuticals, Inc.-Preclinical, 2015 9
Acumen Pharmaceuticals, Inc.-Pipeline by Target, 2015 15
Acumen Pharmaceuticals, Inc.-Pipeline by Molecule Type, 2015 16
Acumen Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action, 2015 17
Acumen Pharmaceuticals, Inc.-Recent Pipeline Updates, 2015 18
Acumen Pharmaceuticals, Inc.-Dormant Developmental Projects,2015 19
List of Figures
Acumen Pharmaceuticals, Inc.-Pipeline by Top 10 Molecule Type, 2015 16
Single User License:
Corporate User License:
Current R&D Portfolio of Acumen Pharmaceuticals, Inc.; Acumen Pharmaceuticals, Inc. - Key Therapeutics; Acumen Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Acumen Pharmaceuticals, Inc. - News; Acumen Pharmaceuticals, Inc. - Latest Updates; Acumen Pharmaceuticals, Inc. - Pipeline; Acumen Pharmaceuticals, Inc. - Discontinued/Dormant Projects